WellKiwis is a study to follow newborns over multiple years, to see how a child’s earliest exposures to the flu virus or flu vaccine influences their immune responses to subsequent flu exposures as a child grows.
The WellKiwis Influenza Study is looking for 600 birth mothers and their children, due to be born between 1 October 2019 to 30 September 2022, to take part in this important study. The purpose of the WellKiwis study is to provide information which will enable scientists and researchers to make more effective and longer lasting flu vaccines for our future populations.
WellKiwis volunteers are being sought in the Wellington region only. This is defined as Wellington central, Hutt Valley and Porirua (the jurisdictions covered by the CCDHB and HVDHB).
Listen to Dr Sue Huang to learn more about WellKiwis
If you are interested in taking part in this study, you can find information here about how YOU and YOUR baby can help develop better vaccines to prevent flu in the future.
You are welcome to contact Dr. Sue Huang or other study staff at freephone 0800 493555 (08004WELLKIWI) with questions about this study.
Or speak to your lead maternity carer, GP or clinician to find out more information and to register your interest.
WellKiwis Participant Information
If you’re interested in signing up to participate in this important study, you can find detailed information here:
You might find answers to some of your questions here in our Frequently Asked Questions [PDF, 910 KB] (FAQs)
To sign up for WellKiwis directly, please email Dr. Sue Huang (lead researcher) at ShiversProject@esr.cri.nz Or phone Dr. Sue Huang on 04 529 0600.
Privacy & Confidentiality
Your child’s test results and information are confidential.
No personal identifiable information will be published.
ESR - one of New Zealand’s Crown Research Institutes - is leading the WellKiwis study with New Zealand ethics approval (NTX11.11.102.AM42). WellKiwis is a member of SHIVERS (Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance) project family. SHIVERS is a long series of research on influenza virus and vaccine and the Wellkiwis study is the third in its series (SHIVERS-III).
WellKiwis is a multi-agency collaboration including Lead Maternity Carer (LMC), the Universities of Otago and Auckland, the Capital Coast and Hutt Valley District Health Boards. It is a part of a large international collaboration on the infant immunity against flu funded by United States National Institutes of Health through the St. Jude Children’s Research Hospital (SJCRH) in Memphis USA.